Hemorrhagic shock (HS) due to major trauma predisposes the host to the development of acute lung inflammation and injury. The lung vascular endothelium is an active organ that plays a central role in the development of acute lung injury (ALI) through generating reactive oxygen species (ROS), and synthesizing and releasing of a number of inflammatory mediators, including leukocyte adhesion molecules that regulate neutrophils emigration. Previous study from our laboratory has demonstrated that in a setting of sepsis, TLR4 signaling can induce TLR2 expression in endothelial cells (EC), and thereby increasing the cells' response to TLR2 ligands.
Introduction
The global ischemia/reperfusion related to resuscitation from hemorrhagic shock (HS) is a major cause of multi-organ failure (MOF), in which acute lung injury (ALI) is an important component and often serves as a direct cause of death (18) . Resuscitated HS is believed to promote the development of lung injury by priming the immune system for an exaggerated inflammatory response to a second, often trivial, stimulus, the so-called "two-hit hypothesis" (41) .
Previous studies have demonstrated that a period of sustained shock followed by resuscitation leads to augmented lung neutrophil sequestration and lung injury in response to a small dose of intratracheal bacterial cell wall constituent, such as LPS (11, 16) . This effect is due, in part, to the increased LPS-stimulated release of cytokines and chemokines from alveolar macrophages (11, 16) . From another aspect, the lung vascular endothelium is a multifunctional cell monolayer that plays important roles in the regulation of vascular tone, coagulation and fibrinolysis, as well as immune and inflammatory responses (6, 25, 37) . Therefore, lung endothelial cells (EC) activation is critically involved in the development of ALI. However, the mechanism underlying HS initiating and enhancing lung EC activation presents a significant gap in our knowledge.
Reactive oxygen species (ROS) have been implicated as important in the pathogenesis of ALI through regulating the expression of a number of inflammatory mediators and activation of signaling pathways (19) . The major source of ROS within EC is the non-phagocytic NAD(P)H oxidase (3), which is composed of membrane-bound gp91 phox and p22 phox , as well as cytosolic subunits such as p47 phox , p67 phox and small GTPase Rac. In addition to these components, EC also express homologues of gp91 phox (Nox2) including Nox1, Nox4, and Nox5. Endothelial NAD(P)H oxidase is activated by many factors including growth factors, cytokines, shear stress, hypoxia, and G-protein coupled receptor agonists (21) . It has been reported that HS-induced P-4 selectin expression in vascular tissue depends on functional NAD(P)H oxidase (1) , suggesting that HS is an initial factor for NAD(P)H oxidase, although direct activation of endothelial NAD(P)H oxidase by HS has not been reported.
The accumulation of polymorphonuclear neutrophils (PMN) in the lung vasculature, interstitium, and alveolar space is considered a critical event in ALI and has been the target of various preventative strategies. The lung EC-derived intercellular adhesion molecule-1 (ICAM-1), a counter receptor for the leukocyte β 2 -integrins LFA-1 and Mac-1 (CD11a/CD18 and CD11b/CD18) (8, 24) , plays an important role in the regulation of PMN sequestration. The interaction of ICAM-1 with CD11/CD18 integrins enables PMN to adhere firmly to the vascular endothelium and thereby migrate across the microvascular barrier (53) . Studies have shown that HS can activate endothelial cells and induce ICAM-1 expression (20, 38, 54, 63) . However, the mechanisms underlying this process have not been fully elucidated.
Toll-like receptors (TLRs), a family of pattern recognition receptors, are now defined as the receptors for recognizing pathogen-associated molecular pattern molecules as well as endogenous molecules released by damaged tissues ("danger signals") (2, 39) . TLR4 and TLR2
sit at the interface of microbial and sterile inflammation by selectively responding to both bacterial products and multiple other endogenous ligands, including hyaluronic acid (56) , heparan sulfate (28) , fibrinogen (52) , heat shock proteins (62) , and high-mobility group box 1 (HMGB1) (43, 60, 61) . Both inflammation and injury responses in organs subjected to ischemia/reperfusion partially depend on TLR4 (46, 60, 61, 69) . Previous studies from both our group and others have demonstrated that EC express a low level of TLR2, which can be upregulated by TLR4 signaling (9, 26) . These studies suggest a mechanism of inducible cellular sensitivity to both exogenous and endogenous stimuli.
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HMGB1 was originally identified as a nuclear protein that functions to stabilize nucleosome formation, and also acts as a transcription factor that regulates the expression of several genes (36) . HMGB1 can be secreted by innate immune cells in response to microbial products or other inflammatory stimuli (64, 66) , and be released by injured cells and known as one of the main prototypes of the emerging damage-associated molecular pattern molecules (DAMPs) (39, 50, 68) . HMGB1 was initially identified as an inflammatory cytokine that is a late mediator of lethality in sepsis (64, 66) . However, recent studies suggest that HMGB1 also acts as an early mediator of inflammation contributing to the development of ALI after trauma/hemorrhage (30, 44, 67) , and hepatic injury after liver ischemia-reperfusion (60).
The present study aimed to test the hypothesis that TLR4 activation by HS and the resultant increased TLR2 expression in EC might contribute to the mechanism underlying the HSaugmented activation of lung EC. The role of HMGB1-TLR4-TLR2 signaling in HS/resuscitation (HS/R)-augmented activation of lung EC was addressed. The study shows that HMGB1/TLR4 signaling mediates the HS-induced increase in TLR2 surface expression and decrease in TLR4 surface expression in the lung as well as in mouse lung vascular endothelial cells (MLVEC). These alterations in TLR4 and TLR2 surface expression result in HMGB1-mediated activation of NAD(P)H oxidase and expression of ICAM-1 in MLVEC that is TLR4-dependent in the early phase and switches to being TLR2-dependent in the late phase following HS. More importantly, the HS-induced surface expression of TLR2 contributes to an enhanced activation of MLVEC and augmented pulmonary PMN infiltration in response to the TLR2 agonist peptidoglycan (PGN). Thus, the present study demonstrates a novel mechanism underlying HS-augmented lung inflammation, namely that induction of increased TLR2 surface expression in lung endothelial cells, which is induced by HS/R and mediated by HMGB1 6 activation of TLR4 signaling, is an important mechanism responsible for EC-mediated inflammation and organ injury following HS/R.
Materials and Methods

Materials
Recombinant HMGB1 was purchased from R&D systems (Minneapolis, MN). Stimulating activity of the recombinant HMGB1 was confirmed in mouse macrophages by assay of TNF release, with an ED 50 of 3 ~ 12 µg/ml. Polyclonal neutralizing antibody against HMGB1 prepared as described previously (66) 
MLVEC Isolation and Characterization
MLVEC were isolated using a previously described method (23, 57) but modified in our laboratory. Briefly, mice were anesthetized with 50 mg/kg of ketamine and 5 mg/kg of xylazine i.p. The chest cavity was opened and the right ventricle was cannulated. Phosphate buffered saline was infused to remove blood from lungs. Peripheral lung tissue dices in a size about 1 8 mm 3 were prepared and cultured in a 60-mm culture dish in growth medium (MEM D-Val medium containing 2 mM glutamine, 10% FBS, 5% human serum, 50 µg/ml penicillin/streptomycin, 5 µg/ml heparin, 1 µg/ml hydrocortisone, 80 µg/ml endothelial cell growth supplement from bovine brain, 5 µg/ml amphotericin, and 5 µg/ml mycoplasma removal agent) at 37°C with 5% CO 2 for 60 h. The adherent cells were continued to culture for 3 days after removal of the tissue dices, followed by purification procedure with biotin-conjugated rat 
Immunoprecipitation and detection of phosphorylated p47 phox
Mouse lung tissue or MLVEC were homogenized or lysed (~1 x 10 6 cells/ml) in lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mM NaF, 1 mM Na 3 VO 4 , 10 µg/ml leupeptin, 10 µg/ml aprotinin and 20 mM PMSF). The supernatants were then immunoprecipitated with anti-p47 phox antibody as described (42) . The immunoprecipitated proteins were separated on a 10% SDS-PAGE gel, and were then electroblotted onto PVDF membrane and blocked for 1 h at room temperature with Tris-buffered saline containing 3% non- 
Measurement of superoxide generation in live MLVEC
Live MLVEC that were cultured in 12-well cell culture plate were stained with the cell permeable ROS detection reagent H2DFFDA (Invitrogen Molecular Probes, Carlsbad, CA) in the concentration of 10 µM for 10 min. The cells were then washed with HBSS for three times followed by incubation in the growth medium in the presence or absence of HMGB1 (0.5 µg/ml) for 8 h. The ROS production was then detected by fluorescence microscopy at different time points.
Reverse transcription and PCR
Total RNA from the lung tissue and MLVEC was isolated using the TRI-REAGENT (Molecular Research Center, Cincinnati, OH) following manufacture's instruction. Total RNA was then reverse-transcribed using a SuperScript Preamplification kit (Invitrogen, Carlsbad, CA).
Primer pairs for mouse TLR2, TLR4 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) amplification were purchased from the R&D System, Inc. (Minneapolis, MN). The product of reverse transcription was amplified following the kit instruction. The amplified product size for TLR2 and TLR4 is 252 bp and 225 bp, respectively, and the PCR products were separated using 1.2% agarose gel and identified by ethidium bromide staining. Expression of mRNA was quantified using Scion Image software (Scion Corp., Frederick, MD) and normalized by the GAPDH signal.
Nuclear protein extraction and NF-κB DAN binding assay
Nuclear protein extracts were prepared from lung tissue or MLVEC by the method of
Deryckere and Gannon (7) . Aliquots of frozen tissue ground to powder with a mortar in liquid 11 nitrogen. The thawed powder or 1 x 10 7 cells were homogenized in a Dounce tissue homogenizer with 4 ml of solution A (0.6% Nonidet P-40, 150 mM NaCl, 10 mM HEPES, pH 7.9, 1 mM EDTA, and 0.5 mM PMSF). The cells were lysed with five strokes of the pestle followed by briefly centrifuging at 2000 rpm for 30 sec. to pellet debris. The supernatant was incubated on ice for 5 min, and centrifuged for 10 min at 5000 rpm. Nuclear pellets were then resuspended in 300 μl of solution B (25% glycerol, 20 mM HEPES, pH 7.9, 420 mM NaCl, 1.2 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 2 mM benzamidine, 5 μg/ml pepstatin, 5 μg/ml leupeptin, and 5 μg/ml aprotinin) and incubated on ice for 20 min. The mixture was centrifuged at 14,000 rpm for 1 min. Supernatants containing nuclear proteins were quantified using the BIO-RAD protein assay dye reagent (BIO-RAD, Hercules, CA). Nuclear NF-κB binding capacity was measured with the non-radioactive NF-κB-p65-DNA binding assay kit (Chicago West Group Inc., Lisle, IL) following the manufacture instruction.
IRAK4 kinase assay
Equal amounts of lung tissue homogenate supernatant were incubated with polyclonal rabbit anti-IRAK-4 antibody for 2 h at 4°C on a rotor, after which 50 µl of 50% protein G plus agarose was added to each sample and incubated for an additional 2 h at 4°C. The samples were precipitated in a microcentrifuge, and the beads were washed twice with lysis buffer and twice with kinase buffer following the kit instruction. The beads were incubated at 25°C for 30 min in a final volume of 37. 
Statistics
The data are presented as mean ± SEM of the indicated number of experiments. Statistical significance among group means was assessed by ANOVA. Student Neuman-Keuls post-hoc test was performed. Differences were considered significant at p<0.01. surface expression in WT MLVEC at as early as 1 h, and reached a peak at 4 h ( Figure 3A ).
Results
HS/R modulates
However, HMGB1 failed to induce an increase in TLR2 surface expression in TLR4-mutant
MLVEC.
Previous studies have shown that activation of TLR4 can signal through both MyD88-dependent and MyD88-independent pathways (22). To determine whether TLR2 expression induced by HMGB1 activation of TLR4 in the MLVEC is a MyD88-dependent event, the MyD88 inhibitor homodimerization inhibitory peptide (35) was applied. MLVEC isolated from TLR4 WT mice were pre-incubated with MyD88 inhibitory peptide (100 µM) for 2 h and subsequently treated with HMGB1 for 6 h. As shown in Figure 3A MyD88 inhibitor significantly attenuated the effect of HMGB1 on TLR2 induction in the MLVEC, suggesting that HMGB1/TLR4 induces TLR2 expression through a MyD88-dependent pathway.
To address the role of NF-κB in mediating HMGB1-induced upregulation of TLR2, the effects of IKK-NBD, an NF-κB inhibitor (5), was assessed on the TLR2 expression in MLVEC.
The NF-κB inhibitor (100 µM) partially but notably attenuated the HMGB1-induced increase in TLR2 expression in WT MLVEC at 6 h after stimulation with HMGB1 ( Figure 3A ). This result indicates an important role for NF-κB signaling in mediating TLR4-TLR2 interaction.
TLR4 surface expression in the MLVEC that were isolated from TLR2 -/-and WT (C57BL/6) mice was also evaluated as shown in Figure 3B . HMGB1 decreased TLR4 surface expression in WT MLVEC as well as in TLR2 -/-MLVEC, excluding a role for TLR2 in mediating the HMGB1-induced decrease in TLR4 surface expression. Inhibitors for MyD88 and NF-κB also did not alter the decreased expression of TLR4 in response to HMGB1 stimulation as well ( Figure 3B ).
TLR4 and TLR2 sequentially mediate HS/R-induced activation of Lung EC
The role of TLR2 and TLR4 in HS/R-induced lung EC activation was addressed. The TLR2-and TLR4-dependency in HS/R-activated IRAK4, NF-κB, NAD(P)H oxidase, and ICAM-1 expression in the lung was measured at 2 h (representing an early phase) and 8 h (representing a late phase). As shown in Figure 4A , HS/R induced a ~12-fold increase in IRAK4 activity and a ~20-fold increase in NF-κB nuclear translocation in the lung at 2 h after HS/R, respectively, and sustained these increases for at least 8 h in WT mice. However, TLR4 mutation significantly attenuated the inductions at both early and late time points. In TLR2 -/-mice, a marked increase in HS/R-induced activities of IRAK4 and NF-κB was observed in the early phase, but not in the late phase. The changes in NAD(P)H oxidase activation, in the form of p47 phox phosphorylation, and ICAM-1 expression in the lung were consistent with the changes in IRAK4 and NF-κB ( Figure 4B ). These results indicate that TLR4 is required for early response of the cells and induction of TLR2 surface expression following HS/R; whereas, increased TLR2 surface expression is critical for a sustained and enhanced response to a HS/R insult.
To confirm that the HS/R-induced ICAM-1 expression is mediated by HMGB1, WT (C3H/HeOuJ) mice were pretreated with neutralizing antibody against HMGB1 before HS/R.
As shown in Figure 5 , neutralizing antibody against HMGB1 markedly attenuated HS/R-induced ICAM-1 expression in the lung at an 8 h time point as compared to that in WT shock mice treated with non-specific IgG. In the experiments shown in Figures 4 and 5 , only C3H/HeOuJ mice were used in order to reduce the usage of WT control mice based on our finding that there was no statistic significance in the changes of multiple parameters, including those shown in Figure 4 , between C3H/HeOuJ and C57BL/6 mice in response to HS/R (data not shown).
The role of TLR2 and TLR4 in the activation of MLVEC by HMGB1 was also studied in vitro. Figure 6A shows that WT MLVEC treated with HMGB1 for 8 h exhibited a sustained activation of NAD(P)H oxidase and ICAM-1 expression. By contrast, HMGB1 failed to induce a high level activation of NAD(P)H oxidase and ICAM-1 expression in TLR4-mutant MLVEC.
However, in TLR2 -/-MLVEC, the HMGB1-induced activation of NAD(P)H oxidase and increased ICAM-1 expression was exhibited in the early phase (1 h), but not in the late phase (8 h) ( Figure 6A ).
To address whether the NAD(P)H oxidase activation is functionally associated with an increase in intracellular ROS production, the ROS in live MLVEC was directly detected using fluorescence microscopy. As shown in Figure 6B , the changes in ROS production in the MLVEC were consistent with the alterations in NAD(P)H oxidase activation as shown in Figure   6A . In order to specify that the ROS is derived from NAD(P)H oxidase, the NAD(P)H oxidase specific inhibitor diphenyleneiodonium (DPI, 100 µM) was added to the MLVEC that were isolated from WT C57BL/6 mice immediately before the treatment of HMGB1. As shown in Figure 6B , DPI markedly diminished the ROS production in the MLVEC in response to HMGB1, indicating that the observed ROS production is mainly derived from NAD(P)H oxidase. MLVEC, but not in TLR4-mutant MLVEC (Figure 3 ). In addition, it has already been reported that HMGB1 levels in serum, lungs and liver were significantly increased within 2 h after HS/R in mice (13) . However, the mechanism by which HS induces HMGB1 release has not been fully addressed. In our previous study it has been demonstrated that macrophage β-adrenergic receptor activation by catecholamines serves as an important mechanism for HS/R-induced HMGB1 secretion (34) . That study showed that a β-adrenergic receptor antagonist could prevent HS/R-induced increase in serum HMGB1, and epinephrine could directly increase serum HMGB1 in vivo. The study also demonstrated that in vitro direct treatment of alveolar macrophages with epinephrine caused HMGB1 release from the cells, and this effect was suppressed by a β-adrenergic receptor antagonist (34).
Increased surface expression of TLR2 mediates HS/R-augmented activation of lung EC
Endothelial NAD(P)H oxidase is a major source of intracellular ROS, which have an important signaling function (19) . ROS in EC contribute to transcriptional regulation of a number of inflammatory mediators through NF-κB (49), AP-1 (c-Jun and c-Fos) (58), and 20 hypoxia-inducible factor1α (HIFα) (4), etc. Importantly, ROS mediate stable ICAM-1 expression-dependent endothelial adhesivity, resulting in the arrest of PMN (27) . Amplified activation of EC NAD(P)H oxidase and expression of ICAM-1 in response to HS/R and PGN were found to be dependent on increased surface expression of TLR2 that is in turn induced by HMGB1-TLR4 signaling (Figure 7) . Thus, the present study explores an important role of shock-induced activation of TLR4 in activating TLR2 signal, which in turn leads to exaggerated lung inflammation.
TLR4 expression in the lung and MLVEC was decreased by HS/R as shown in the results.
How HS/R down-regulates TLR4 is not clear but it appears that the downregulation of TLR4 is dependent on HMGB1 but is not mediated by a pathway that involves MyD88, NF-κB or TLR2
signaling, since suppression of MyD88 and NF-κB activation, as well as TLR2 deficiency, did not prevent the TLR4 decrease in HMGB1-stimulated MLVEC. Previous study from our laboratory has shown that in alveolar macrophages LPS down-regulates TLR4 and that HS/R attenuated the effect of LPS (12) . This modulation may serve as a mechanism by which the role of TLR4 signaling is prolonged and the resultant inflammatory response induced by TLR4 signaling is enhanced in HS/R (12) . The present study, however, revealed a different mechanism of HS/R regulation of TLR4. Nevertheless, HS either acting as a pre-conditioning factor to prevent TLR4 decrease in response to LPS or working as a coordinator to transfer the signaling momentum from TLR4 to TLR2 through inducing TLR2 expression in a setting without LPS stimulation is believed to be important in promoting the development of inflammation and organ injury after HS/R.
Perspectives and Significance
21
The burden of disease related to trauma is considerable. The epidemiology of trauma mortality suggests two major phases. In the early phase, death most commonly results from neurologic injury and/or exsanguination. During the later phase, more than 7 days posttrauma, more than 60% of patients die of causes related to the development of SIRS.
Because of the time lag in the onset of organ dysfunction and subsequent failure, this patient population is well suited to prophylactic interventions aimed at preventing these occurrences.
Since EC plays important and broad roles in HS-induced inflammation, an insight of the mechanisms of HS initiation of EC activation will provide us novel targets for preventive and therapeutic interventions of post-HS SIRS and ALI. In a broader sense, the studies in this field will contribute to a greater understanding of the pathogenesis of a number of human inflammatory diseases in which endothelium is involved in the inflammatory process. 
